Cardiomyopathy Trial, Recruiting NCT06570902 Sponsor: Zoll Medical Corporation Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06570902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had their first-ever coronary artery bypass graft (heart bypass) surgery less than 10 days before joining the study.
  • People whose doctor prescribed a wearable defibrillator vest (a device worn on the body that can detect and treat dangerous heart rhythms) primarily because their heart's pumping function was found to be below 35% after surgery but before leaving the hospital.
  • People who are 18 years old or older.

Who may not be able to join:

  • People who had heart valve repair done at the same time as their bypass surgery.
  • People who have had a previous bypass surgery before this one.
  • People who have an active single-lead (unipolar) pacemaker device.
  • People who have a physical or mental health condition that could make it difficult to use the wearable defibrillator vest correctly.
  • People who are currently taking part in another interventional clinical study (a study that involves a treatment or procedure being tested).
  • People who have a skin condition that would prevent them from wearing the vest device.
  • People who have a formal advance directive (a legal document) that states they do not wish to be resuscitated.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 015161140498

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zoll Medical Corporation
Registry
ClinicalTrials.gov
Start date
23 September 2024
Est. completion
1 November 2029

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

EF recovery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov